Northwestern Medicine investigators recently discovered that the mitochondrial respiratory chain — a series of protein complexes essential for a cellular respiration and energy production — is ...

TBI remains a major cause of death and long-term neurological disability worldwide, yet effective treatments for secondary injury are still lacking.

A Signaling Nexus for Both Good and Ill, It’s Pathways of Pathogenic and Therapeutic Importance Are Still Being Identified A recent paradigm shift in medicine started with the finding that several ...

First-in-class clinical trial in dry AMD with new drug specifically designed to inhibit inflammasome activation in the eye and to be administered locally via a newly designed sustained release implant ...

This work was supported by grants from the National Natural Science Foundation of China (Nos. 82471497, 82311530117, and ...

A team of researchers, affiliated with UNIST have unraveled the molecular mechanisms behind the activation of multiple inflammasomes and their role in inducing inflammatory cell death. This discovery ...

NEWTON, Mass.--(BUSINESS WIRE)--Inflammasome Therapeutics (https://www.inflam.com/), a clinical-stage biotech company developing novel, first-in-class dual ...

This study was collaboratively performed by Dr. Shu-Hong Yu, Dr. Long-Ping Wen, and Dr. Kun Qu from the University of Science and Technology of China, with Professor Yang Lu from the Hefei University ...

Research on the diversity of T cell receptor repertoire in the process of malignant transformation of HBV chronic infection. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This ...

Every morning of his life, no matter what he did, a young British man woke up with a fever, a headache, a rash on his trunk and limbs, joint pain, and ever-worsening deafness. His doctors had ...